Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP5PF pseudogene 2 (ATP5PFP2) is classified as a pseudogene. Pseudogenes are genomic DNA sequences similar to normal genes but nonfunctional; they usually arise by gene duplication or retrotransposition. ATP5PFP2 is related by sequence to ATP5PF, which encodes the ATP synthase peripheral stalk subunit F6 (a component of the mitochondrial ATP synthase complex involved in cellular energy production). However, ATP5PFP2 does not encode a protein and is not considered a therapeutic target, enzyme, transporter, receptor, enzyme modulator, or any other actionable biomolecule in drug discovery or clinical medicine[7][3]. No established aliases, biological functions, molecular interactions, disease associations, biomarker roles, interacting drugs, drug mechanisms, or safety concerns are cited for this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP5PF pseudogene 2 (ATP5PFP2).